SPECTRAL AI, INC. (MDAI) Operating Margin
- Operating margin · 12 months: Value -77.17%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -77.17% | Operating income / revenue. Period ending 2026-06-30. $-11.88M ÷ $15.39M × 100 ≈ -77.17% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -11.88M USD | Operating Income (Loss) |
| Revenue | 15.39M USD | |
| Cost of products and services | (m) | |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-11.88M | $15.39M | (m) | (m) | (m) | -77.17% |
| 2026-03-31 | $-9.68M | $16.93M | (m) | (m) | (m) | -57.15% |
| 2025-12-31 | $-8.60M | $19.65M | (m) | (m) | (m) | -43.78% |
| 2025-09-30 | $-7.47M | $23.17M | (m) | (m) | (m) | -32.25% |
| 2025-06-30 | $-5.02M | $27.55M | (m) | (m) | (m) | -18.21% |
| 2025-03-31 | $-5.33M | $29.96M | (m) | (m) | (m) | -17.81% |
| 2024-12-31 | $-6.58M | $29.58M | (m) | (m) | (m) | -22.25% |
| 2024-09-30 | $-8.40M | $27.26M | (m) | (m) | (m) | -30.81% |
| 2024-06-30 | $-11.68M | $22.53M | (m) | (m) | (m) | -51.84% |
| 2024-03-31 | $-12.23M | $19.30M | (m) | $15.40M | (m) | -63.35% |
| 2023-12-31 | $-12.98M | $18.06M | (m) | $15.10M | (m) | -71.91% |
| 2023-09-30 | $-10.43M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $-2.54M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $-1.31M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $-1.25M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $-2.73M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $-3.69M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $-3.73M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $-3.42M | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |